8-K: American Rebel Holdings Acquires Stake in Schmittys Snuff

American Rebel Holdings, Inc. has acquired a 19.01% ownership interest in non-tobacco, non-nicotine oral product manufacturer Sydona Enterprises, LLC, d/b/a Schmittys Snuff, for approximately $2 million in stock and warrants.

Summary

• American Rebel Holdings, Inc. (AREB) entered into a Minority Membership Interest Purchase Agreement with Sydona Enterprises, LLC, d/b/a Schmittys Snuff, on September 2, 2025.
• AREB acquired 31,603.20 common units in Schmittys, representing a 19.01% ownership interest.
• The aggregate purchase price for the ownership interest was $1,999,850.59.
• Consideration included 426,155 shares of AREB common stock and a prefunded warrant to purchase 1,183,191 shares of common stock.
• The parties agreed to a value of $1.25 per share of common stock and $1.24 per prefunded warrant for the transaction.
• A 4.99% beneficial-ownership blocker was included for Schmittys' ownership of AREB's outstanding common stock.
• AREB is obligated to file a Form S-1 registration statement with the SEC within 5 business days to register the issued shares and shares underlying the prefunded warrants.
• Schmittys Snuff manufactures and distributes premium non-tobacco, non-nicotine oral products, emphasizing food-grade ingredients and compliance with FDA regulations.

Sentiment

Score: 7

Explanation: The filing describes a strategic investment into a growing market segment (non-tobacco, non-nicotine oral products) with a company that has demonstrated market traction. While there is dilution from the issuance of shares and warrants, the move is generally positive for diversification and potential growth, assuming successful integration and market performance of Schmittys.

Positives

• Strategic investment in the growing non-tobacco, non-nicotine oral product market, diversifying American Rebel Holdings' portfolio.
• Schmittys Snuff has a strong direct-to-consumer presence, 7-Eleven corporate adoption, and high sell-through and re-order performance at retail.
• Schmittys' commitment to quality, innovation, and consumer health aligns with increasing market demand for healthier alternatives.
• The acquisition provides American Rebel Holdings with exposure to a company with potential FDA-reviewed SKUs.

Negatives

• The issuance of 426,155 shares of common stock and prefunded warrants for 1,183,191 shares will result in dilution for existing American Rebel Holdings shareholders.
• The prefunded warrants, if exercised, will lead to further dilution of common stock ownership.

Risks

• Market acceptance and sustained growth of non-tobacco, non-nicotine oral products are crucial for the success of this investment.
• Ongoing compliance with FDA labeling and packaging requirements and other health and safety regulations for Schmittys' products poses a regulatory risk.
• Intense competition in the oral product market could impact Schmittys' market share and profitability.
• Potential challenges in integrating Schmittys' operations or realizing expected synergies from the minority investment.
• Future dilution from the exercise of prefunded warrants could impact per-share value for existing shareholders.

Future Outlook

American Rebel Holdings plans to file a Form S-1 registration statement within five business days of the closing to register the shares of common stock and shares underlying the prefunded warrants. Schmittys Snuff is expected to continue expanding its product portfolio with new innovations and potential FDA-reviewed SKUs, supported by its strong direct-to-consumer presence and retail adoption.

Management Comments

• American Rebel Holdings entered into a Membership Interest Purchase Agreement with Sydona Enterprises, LLC, d/b/a Schmittys Snuff.
• Schmittys Herbal Snuff and Pouches is a Washington-based manufacturer and distributor of premium non-tobacco, non-nicotine oral products, committed to quality, innovation, and consumer health, offering flavorful and satisfying alternatives for adult consumers seeking smokeless options without tobacco or nicotine.

Industry Context

This strategic investment positions American Rebel Holdings in the rapidly expanding non-tobacco, non-nicotine oral product market, which is driven by increasing consumer demand for healthier alternatives to traditional tobacco products. Schmittys Snuff's established direct-to-consumer and retail presence, including 7-Eleven corporate adoption, indicates strong market traction within this growing segment, aligning with broader industry trends towards wellness and reduced-harm products.

Corporate Governance

Stakeholder Impact

• Shareholders of American Rebel Holdings will experience dilution from the issuance of common stock and prefunded warrants, but may benefit from strategic diversification into a growing market segment.
• Shareholders of Sydona Enterprises, LLC (Schmittys Snuff) receive equity in American Rebel Holdings in exchange for a minority interest in their company, potentially gaining liquidity and exposure to a public market.
• Customers of Schmittys Snuff are likely to see no direct immediate impact, but there is potential for increased product development and market reach through the new ownership structure.
• Management of American Rebel Holdings is now responsible for integrating this new investment and realizing its strategic benefits.
• Management of Schmittys Snuff will continue to operate the business with a new minority equity partner.

Next Steps

• American Rebel Holdings to prepare and file a Form S-1 registration statement with the SEC within 5 business days of September 2, 2025, to register the issued shares and shares underlying the prefunded warrants.
• Schmittys Snuff is expected to continue expanding its product portfolio with new product innovations and potential FDA-reviewed SKUs.

Key Dates

Recommendation

This filing details a strategic minority investment by American Rebel Holdings into Schmittys Snuff, a non-tobacco, non-nicotine oral product manufacturer. While the move diversifies AREB's portfolio into a growing market and Schmittys has demonstrated market traction, the transaction involves significant equity issuance, leading to dilution for existing shareholders. Without detailed financial projections or performance metrics for Schmittys, it is difficult to assess the immediate financial impact or the long-term value creation potential. Investors should hold to observe the integration, future financial disclosures, and market performance of Schmittys under AREB's partial ownership.

Keywords

American Rebel Holdings, Schmittys Snuff, non-tobacco, non-nicotine, oral products, membership interest purchase, strategic investment, common stock, prefunded warrants, FDA compliance, consumer health, smokeless options